Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience.
| Autor: | Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, Grossman PM, Goldman CK, McEllin K, Kelly R, Chronos N |
|---|---|
| Zdroj: | Circulation; 3/13/2007, Vol. 115 Issue 10, p1234-1243, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|